K-Ras and MSI: Potential Markers of Both Patient Prognosis and Treatment Efficacy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1534-4681
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
K-Ras and MSI: Potential Markers of Both Patient Prognosis and Treatment Efficacy ; volume:17 ; number:2 ; day:20 ; month:11 ; year:2009 ; pages:354-355 ; date:2.2010
Annals of surgical oncology ; 17, Heft 2 (20.11.2009), 354-355, 2.2010
- Urheber
-
Turaga, Kiran
Shibata, David
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1245/s10434-009-0712-1
- URN
-
urn:nbn:de:101:1-2021082521354456185513
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Turaga, Kiran
- Shibata, David
- SpringerLink (Online service)
Ähnliche Objekte (12)
Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP
K-Ras protein as a drug target
Unraveling (K)RAS in pancreatic ductal adenocarcinoma
Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression
K-Ras prenylation as a potential anticancer target
Drugging the Undruggable using Irreversible Covalent K-Ras G12C Inhibitors
RARB associated with MSI, affects progression and prognosis of gastric cancer
*MSiAR
*MSiE*
Coexistence of K-ras mutations and HPV infection in colon cancer
Namenverzeichnis M-Si
Mutationsanalysen von K-ras und p53 bei Patienten mit Plattenepithelkarzinom des Ösophagus
Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP
K-Ras protein as a drug target
Unraveling (K)RAS in pancreatic ductal adenocarcinoma
Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression
K-Ras prenylation as a potential anticancer target
Drugging the Undruggable using Irreversible Covalent K-Ras G12C Inhibitors
RARB associated with MSI, affects progression and prognosis of gastric cancer
*MSiAR
*MSiE*
Coexistence of K-ras mutations and HPV infection in colon cancer
Namenverzeichnis M-Si
Mutationsanalysen von K-ras und p53 bei Patienten mit Plattenepithelkarzinom des Ösophagus
Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP
K-Ras protein as a drug target
Unraveling (K)RAS in pancreatic ductal adenocarcinoma
Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression
K-Ras prenylation as a potential anticancer target
Drugging the Undruggable using Irreversible Covalent K-Ras G12C Inhibitors
RARB associated with MSI, affects progression and prognosis of gastric cancer
*MSiAR
*MSiE*
Coexistence of K-ras mutations and HPV infection in colon cancer
Namenverzeichnis M-Si